[Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene]

Autor: Ea, Romanovskaia-Roman Ko, Boris FERKO, Oi, Vyshemirskiĭ, Romanova IuR, Krenn B, Muster T, Mp, Grudinin, Ba, Lapin, Egorov AIu, Oi, Kiselev

Publikováno v: Europe PubMed Central

The paper gives the results of evaluating the efficiency of deINS1 pandemic H5N1 vaccine candidate VN1203delNS1 which was constructed by reverse genetics on the basis of influenza virus strain A/Vietnam/1203/04. The safety, immunogenicity and cross-p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e2c8f766e8667076891d60215ab08e67
https://pubmed.ncbi.nlm.nih.gov/22359944

[Human papilloma virus and lymphatic metastasis in squamous cell carcinoma of the cervix]

Autor: Elena Bakhidze, Oe, Lavrinovich, Of, Chepik, Oi, Kiselev

Publikováno v: Europe PubMed Central

Our study included 112 patients with squamous cell cervical carcinoma la-lib stages (FIGO). All of them were restaged on the basis of histological evidence after surgical treatment. Ninety-eight were staged at final analysis. Human papilloma virus (H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3d3c7b571e0e6c07d4484a6e6c1907b5
https://pubmed.ncbi.nlm.nih.gov/21882602

[Protective activity of Ingavirin in experimental lethal influenza due to pandemic influenza virus A (H1N1)v in albino mice]

Autor: Vv, Zarubaev, Av, Garshinina, Na, Kalinina, Aa, Shtro, Sv, Beliaevskaia, Ve, Nebol Sin, Oi, Kiselev

Publikováno v: Europe PubMed Central

Despite obvious success in the vaccine development and chemotherapy of influenza, it remains a poorly controlled infection leading to emergence of new pandemic variants of the virus with high morbidity and mortality. We investigated the protective ac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f37312cdc2afad2353e0ce63187e197b
https://pubmed.ncbi.nlm.nih.gov/21033471

Recombinant influenza vaccines

Autor: Es, Sedova, Dn, Shcherbinin, Ai, Migunov, Smirnov IuA, Denis Logunov, Mm, Shmarov, Lm, Tsybalova, Bs, Naroditskiĭ, Oi, Kiselev, Al, Gintsburg

Publikováno v: Europe PubMed Central
Acta Naturae

This review covers the problems encountered in the construction and production of new recombinant influenza vaccines. New approaches to the development of influenza vaccines are investigated; they include reverse genetics methods, production of virus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::82d080edf6799224dbbcbe7b42087298
http://europepmc.org/abstract/med/23346377

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

Autor: Ponomarenko DM; Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation., Klimova ID; Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation., Chapygina YA; Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation., Dvornichenko VV; Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation., Zhukova NV; Saint-Petersburg City Clinical Oncology Dispensary, Saint-Petersburg, Russian Federation., Orlova RV; Saint-Petersburg City Clinical Oncology Dispensary, Saint-Petersburg, Russian Federation.; Saint-Petersburg University, Saint-Petersburg, Russian Federation., Manikhas GM; Saint-Petersburg City Clinical Oncology Dispensary, Saint-Petersburg, Russian Federation.; Pavlov First Saint Petersburg State Medical University, Saint- Petersburg, Russian Federation., Zyryanov AV; Multidisciplinary Clinical Medical Center 'Medical City', Tyumen, Russian Federation., Burkhanova LA; Multidisciplinary Clinical Medical Center 'Medical City', Tyumen, Russian Federation., Badrtdinova II; Multidisciplinary Clinical Medical Center 'Medical City', Tyumen, Russian Federation., Oshchepkov BN; Multidisciplinary Clinical Medical Center 'Medical City', Tyumen, Russian Federation., Filippova EV; Pavlov First Saint Petersburg State Medical University, Saint- Petersburg, Russian Federation., Orlov SV; Pavlov First Saint Petersburg State Medical University, Saint- Petersburg, Russian Federation., Kolesnikov SI; Russian Academy of Sciences, Moscow, Russian Federation., Sufianov AA; Federal Center of Neurosurgery, Tyumen, Russian Federation.; Sechenov First Moscow State Medical University, Moscow, Russian Federation., Baum SR; Synergy Research Group, Moscow, Russian Federation., Zaitzeva OY; Synergy Research Group, Moscow, Russian Federation., Komissarov AB; Research Institute of Influenza, Saint-Petersburg, Russian Federation., Grudinin MP; Research Institute of Influenza, Saint-Petersburg, Russian Federation., Kiselev OI; Research Institute of Influenza, Saint-Petersburg, Russian Federation., Tsyb AF; A. Tsyb Medical Radiological Research Center, Obninsk, Russian Federation., Venanzi F; Department of Biology MCA, University of Camerino, Italy., Shcherbinina V; CL Oncology, LLC, Moscow, Russian Federation., Chursov A; CL Oncology, LLC, Moscow, Russian Federation.; CureLab Oncology, Inc, Dedham, MA, USA., Gabai VL; CL Oncology, LLC, Moscow, Russian Federation.; CureLab Oncology, Inc, Dedham, MA, USA.; Department of Biochem, Boston University School of Medicine, Boston, MA, USA., Shneider AM; Sechenov First Moscow State Medical University, Moscow, Russian Federation.; CureLab Oncology, Inc, Dedham, MA, USA.; Department of Molecular Biology, Ariel University, Ariel, Israel.

Publikováno v: Oncotarget [Oncotarget] 2017 Mar 25; Vol. 8 (32), pp. 53730-53739. Date of Electronic Publication: 2017 Mar 25 (Print Publication: 2017).